ABSTRACT
Inflammation modulation is currently considered a promising therapeutic strategy to counteract the burden of cardiovascular disease. Amentoflavone (AME) is a natural biflavone with two apigenin molecules that, possess promising anti-inflammatory, anti-oxidative, and anti-cancer properties. In the present study, we aimed to investigate the effects of AME on myocardial ischemia-reperfusion injury in vivo and in vitro, and to elucidate the underlying mechanism. Our results showed that AME significantly reduced the levels of LDH, CK-MB, IL-6, IL-1ß, and TNF-α after hypoxia (H) 12 h/reoxygenation (R) 4 h treatment, and significantly increased the cell survival rate of H9c2 cardiomyocytes induced by H/R and inhibited their apoptosis rate. AME (25, 50, 100 mg·kg-1·d-1, i.g.) or a positive control drug diltiazem (DIZ) (16 mg·kg-1·d-1, i.g.) was used as pretreatment for 7 days; the myocardial ischemia-reperfusion(I/R) model was established. TTC staining results showed that the infarct volume was significantly reduced after AME and DIZ treatment. Oral administration of AME dose-dependently ameliorated I/R injury-induced increase in pro-inflammatory factors (IL-6, IL-1ß, and TNF-α) and levels of LDH and CK-MB. Results of TUNEL and HE staining showed that the I/R model had more induced apoptosis, but could be effectively reduced by pretreatment with AME. After surgery, the heart of the rat was examined via western blotting to detect inflammation-related proteins. Compared with the sham group, the p-AKT in the I/R group was significantly reduced and the content of p-NF-κBp65 was significantly increased. However, these changes could be reversed by AME treatment. DIZ treatment exerted similar beneficial effects in I/R rats as the high dose of AME did. This study highlights the excellent therapeutic potential of AME for managing myocardial ischemia-reperfusion injury.
Subject(s)
Myocardial Reperfusion Injury/drug therapy , Animals , Apigenin/pharmacology , Apoptosis/drug effects , Biflavonoids , Inflammation/drug therapy , Interleukin-1beta , Male , Myocardial Ischemia/drug therapy , Myocardium/metabolism , Myocytes, Cardiac/drug effects , NF-kappa B/metabolism , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley , Tumor Necrosis Factor-alpha/metabolismABSTRACT
AIM@#To study the dibenzocylooctadiene lignans from the stems of Kadsura heteroclita.@*METHOD@#Chromatographic separations of silica gel and semi-preparative HPLC were used. All of the structures were elucidated on the basis of spectroscopic analysis, including 2D-NMR and HR-MS techniques.@*RESULTS@#Four dibenzocylooctadiene lignans were isolated from K. heteroclita. Their structures were identified as heteroclitin R (1), heteroclitin S (2), gonisin O (3), and schisanlignone A (4).@*CONCLUSION@#Heteroclitin R (1) and heteroclitin S (2) are new natural lignans.
Subject(s)
Kadsura , Chemistry , Lignans , Chemistry , Molecular Structure , Plant Extracts , ChemistryABSTRACT
OBJECTIVE: To study the chemical constituents of Herpetospermum caudigerum. METHODS: The chemical constituents were isolated by silica gel, Sephedex LH-20 and MCI methods. Their structures were elucidated by physical-chemical properties and spectroscopic methods such as UV, IR, ESI-MS, H-NMR and 13 C-NMR. RESULTS: Seven compounds were isolated and identified as Herpetolide A (1), Herpetolide B (2), Dehydrodiconiferyl alcohol (3), Herpetol (4), Arbutin, 1-acetate (5), Dodecanoic acid (6) and 10-Eicosenoic acid (7). CONCLUSION: compounds 5-7 are isolated from this plant for the first time.
